Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2021-07-09

Clinical Trial Update: A Study to Evaluate the Safety and Efficacy of AstroStem in Treatment of Alzheimer's Disease [Phase 1, Phase 2]

View source ↗

Summary

A completed Phase 1/2 clinical trial evaluating the safety and efficacy of AstroStem for Alzheimer's disease has results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • AstroStem

Snippet

Sponsor: Nature Cell Co. Ltd. | Conditions: Alzheimer Disease | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2021-07-09